Retroviral transfer of herpes simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector

Leukemia Research

Volumn 21, Issue 10, 1997, Pages 951-959

  Di Ianni, Mauro ^a   Casciari, Carla ^a   Ciurnelli, Raffaella ^a   Fulvi, Antonella ^a   Bagnis, Claude ^b   Sadelain, Michael ^c   Lucheroni, Francesca ^a   Mannoni, Patrice ^b   Stella, Carmelo Carlo ^d   Martelli, Massimo F ^a   Tabilio, Antonio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b INSTITUT PAOLI CALMETTES   (France)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

Bacterial beta galactosidase gene; Bicistronic vector; Herpes simplex virus thymidine kinase gene; IRES sequence; Retroviral transfer; U937

Indexed keywords

BETA GALACTOSIDASE; FLUORESCEIN; GANCICLOVIR; PYRANOSIDE; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; FLUORESCENCE ACTIVATED CELL SORTER; HERPES SIMPLEX VIRUS; HISTOCHEMISTRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; RETROVIRUS; RIBOSOME;

BETA-GALACTOSIDASE; CLONING, MOLECULAR; DNA, VIRAL; ENCEPHALOMYOCARDITIS VIRUS; FLOW CYTOMETRY; GALACTOSIDES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNOPHENOTYPING; INDOLES; LAC OPERON; PHENOTYPE; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; RETROVIRIDAE; RNA, VIRAL; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030828173     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00074-X     Document Type: Article

References (35)

1. Emerman, M. and Temin, H. M., Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell, 1984, 39, 459.
2. Emerman, M. and Temin, H. M., Quantitative analysis of gene suppression in integrated retrovirus vectors. Molecular and Cellular Biology, 1986, 6, 792.
3. Germann, U. A., Chin, K. V., Pastan, I. and Gottesmann, M. M., Retroviral transfer of a chimeric multidrug resistance-adenosine deaminase gene. FASEB Journal, 1990, 4, 1501.
4. Sokolic, R. A., Sekhsaria, S., Sugimoto, Y., Whitingtheobald, N., Linton, G. F., Li, F., Gottesmann, M. M. and Malech, H. L., A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression. Blood, 1996, 87, 42.
5. Ghattas, I. R., Sanes, J. R. and Majors, J. E., The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and embryos. Molecular and Cellular Biology, 1991, 11, 5848.
6. Davies, M. and Kaufman, R. J., The sequence context of the initiation codon in the encephalomyocarditis virus leader modulates efficiency of internal translation initiation. Journal of Virology, 1992, 66, 1924.
7. Jang, S. K. and Wimmer, E., Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Development, 1990, 4, 1560.
8. Morgan, R. A., Couture, L., Elroy-Stein, O., Ragheb, J., Moss, B. and Anderson, W. F., Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Research, 1992, 20, 1293.
9. Sugimoto, Y., Aksentijevich, I., Murray, G. J., Brady, R. O., Pastan, I. and Gottesmann, M. M., Retroviral coexpression of a multidrug resistance gene (MDR1) and human alpha-galactosidase A for gene therapy of Fabry disease. Human Gene Therapy, 1995, 6, 905.
10. Hsieh, C. L., Chen, B. F. F., Wang, C. C., Liu, H. H., Chen, D. S. and Hwang, L. H., Improved gene expression by a modified bicistronic retroviral vector. Biochemical and Biophysical Research Communications, 1995, 214, 910.
11. Culver, K. W. and Blaese, M., Gene therapy for cancer. Trends in Genetics, 1994, 10, 174.
12. Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H. and Blaese, R. M., In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science, 1992, 256, 1550.
13. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J. L. and Klatzmann, D., Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proceedings of the National Academy of Science of the USA, 1993, 90, 7024.
14. Tiberghien, P., Reynolds, C. W., Keller, J., Spence, S., Deschaseaux, M., Certoux, J. M., Contassot, E., Murphy, W. J., Lyons, R., Chiang, Y., Herve, P., Longo, D. L. and Ruscetti, F. W., Ganciclovir treatment of Herpes Simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood, 1994, 84, 1333.
15. Mavilio, F., Ferrari, G., Rossini, S., Nobili, N., Bonini, C., Casorati, G., Traversari, C. and Bordignon, C., Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood, 1994, 83, 1988.
16. Golumbek, P. T., Hamzeh, F. M., Jaffee, E. M., Levitsky, H., Lietman, P. S. and Pardoll, D. M., Herpes simplex-1 virus thymidine kinase is unable to completely eliminate live, non immunogenic tumor cell vaccines. Journal of Immunotherapy, 1992, 12, 224.
17. Ram Z., Culver K. W., Oshiro E. M., Raman R., Moen R. C., Devroom H. L., Blaese R. M. and Oldfield E. H., Gene therapy for malignant brain tumors: preliminary results of a clinical study using retroviral-mediated in situ transduction with the herpes thymidine kinase gene and ganciclovir. Cancer Gene Therapy 1993/1994, 1 (Suppl. 1) (abstract No. 1-I).
18. Bagnis, C., Gravis, G., Imbert, A. M., Herrera, D., Allario, T., Galindo, R., Lopez, M., Pavon, C., Sempere, C. and Mannoni, P., Retroviral transfer of the nlsLacZ gene into human CD34 + cell populations and into TF-1 cells: future prospects in gene therapy. Human Gene Therapy, 1994, 5, 1325.
19. Macgregor, G. R., Mogg, A. E., Burke, J. F. and Caskey, C. T., Histochemical staining of clonal mammalian cell lines expressing E. coli β-galactosidase indicates heterogeneous expression of the bacterial gene. Somatic and Cell Molecular Genetics, 1987, 13, 253.
20. Bagnis, C., Chabannon, C. and Mannoni, P., Marking human progenitors and T lymphocytes with β-galactosidase genes. Cancer Gene Therapy, in press.
21. Nolan, G. P., Fiering, S., Nicolas, J. F. and Herzenberg, L. A., Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of E. coli LacZ. Proceedings of the National Academy of Science of the USA, 1988, 85, 2603.
22. Sundstrom, C. and Nilsson, K., Establishment and characterization of a human histiocytic lymphoma cell line (U-937). International Journal of Cancer, 1976, 17, 565.
23. Markowitz, D. S., Goff, S. and Bank, A., A safe packaging line for gene transfer: separating viral genes on two different plasmids. Journal of Virology, 1988, 62, 1120.
24. Markowitz, D. S., Goff, S. and Bank, A., Construction and use of a safe and efficient packaging cell line. Virology, 1988, 85, 400.
25. Danos, O. and Mulligan, R. C., Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proceedings of the National Academy of Science of the USA, 1988, 85, 6460.
26. Lynch, C. M. and Miller, A. D., Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different hostranges. Journal of Virology, 1991, 65, 3887.
27. Shapiro, H. M., Parameters and probes. In Practical Flow Cytometry, 3rd edn, Wiley-Liss, New York, pp. 229-348.
28. Maniatis, T., Fritsch, E. F. and Sambrook, J., Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp. 189-389.
29. Varmus, H., Retroviruses. Science, 1988, 240, 1427.
30. Imbert, A. M., Costello, R., Imbert, J., Mannoni, P. and Bagnis, C., Highly efficient retroviral gene transfer into human primary T-lymphocytes derived from the peripheral blood. Cancer Gene Therapy, 1994, 1, 259-265.
31. Di Ianni, M., Casciari, C., Ciurnelli, R., Fulvi, A., Bagnis, C., Lucheroni, F., Falzetti, F., Mannoni, P., Martelli, M. F. and Tabilio, A., Beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocytes reaction. Haematologica, 1996, 81, 410.
32. Hoeben, R. C., Migchielsen, A. A. J., Van Der Jagt, R. C. M., Van Ormondt, H. and Van Der Erb, A. J., Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell line is associated with methylation and dependent on its chromosomal position. Journal of Virology, 1991, 65, 904.
33. Abe, A., Takeo, T., Emi, N., Tanimoto, M., Ueda, R., Yee, J. K., Friedmann, T. and Saito, H., Transduction of a drug sensitive toxic gene into human leukemia cell line with a novel retroviral vector. Proceedings of the Society of Experimental Biological Medicine, 1993, 203, 354.
34. Oldfield, E. H., Ram, Z., Culver, K. W., Blaese, R. M., Devroom, H. L. and Anderson, W. F., Gene therapy for the treatment of brains tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Human Gene Therapy, 1993, 4, 39.
35. Cesano, A., Hoxie, J. A., Lange, B., Nowell, P. C., Bishop, J. and Santoli, D., The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias. Oncogene, 1992, 7, 827.